Loading chart…
PRE-MARKET
Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins and injectable cephalosporins; human and veterinary products; and antibiotics, including beta-lactam. It serves pharma companies, generic drug manufacturers, healthcare distributors, and institutional and government buyers.
Orchid Pharma Limited (ORCHPHARMA) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The ORCHPHARMA share price is ₹868.00 (-3.09% today), with a market capitalisation of ₹44B and a price-to-earnings (P/E) ratio of 539.1. MarketRipple tracks the ORCHPHARMA investment thesis, the ripple-chain impact of market events on Orchid Pharma Limited, and the Healthcare sector outlook.
Open
₹896.75
High
₹896.75
Low
₹862.55
Prev. Close
₹895.65
52W High
₹1,143.50
52W Low
₹480.00
Day range
₹862.55–₹896.75
52-week range
₹480.00–₹1,143.50
Volume
31K
P/E
539.1
ROE
0.6%
D/E
0.20
Margin
3.5%
Orchid Pharma Limited (NSE: ORCHPHARMA) is currently trading at ₹868.00 (-3.09%).
Orchid Pharma Limited's market capitalization is ₹44B.
Orchid Pharma Limited's price-to-earnings (P/E) ratio is 539.1.
Orchid Pharma Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Orchid Pharma Limited currently reads neutral, based on 3 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.